Overview A Study of KL130008 in Adults With Severe Alopecia Areata Status: Not yet recruiting Trial end date: 2024-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to assess KL130008 is safe and effective in adults with severe alopecia areata Phase: Phase 2 Details Lead Sponsor: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.